This systematic review reports that trichoscopy is highly accurate for diagnosing scalp disorders, suggesting it as a valuable alternative to biopsies and supporting recommendations for its integration into routine dermatology practice.
This audit of ritlecitinib prescribing for severe alopecia areata found that regional practices largely followed national guidelines but highlighted the need for better psychological assessments and more consistent use of SALT scoring to inform treatment continuation decisions after 36 weeks.
81 citations
,
January 2011 in “European Journal of Internal Medicine”
This review updates on the understanding and management of eating disorders, noting substantial progress over 30 years but highlighting the need for revised classification, clarified pathogenesis, and improved treatments.
Microneedling can promote hair growth, but there is uncertainty about the best practices, including needle length, device, and session frequency. Users discuss using needle lengths between 0.5mm and 1.5mm, with some experiencing pinpoint bleeding, and emphasize the need for more reliable resources and guidelines.
There is no reliable ranking for the effectiveness of topical anti-androgens like Fluridil, RU58841, and Pyrilutamide, with limited studies available. Some users suggest Pyrilutamide may be promising based on ongoing trials, while Fluridil combined with finasteride has shown positive results for some individuals.
Microneedling may stimulate hair regrowth independently and could potentially enhance the effects of oral minoxidil, though evidence is limited. Some users report positive results with microneedling, but concerns about scarring and the need for proper technique are noted.
The conversation discusses the legitimacy and reputation of various Indian brands of dutasteride, with recommendations for Dr. Reddy's, Cipla's Duprost, and Intas's Veltride/Dutaman as reputable options. The company in question is noted for exporting but is not well-known locally, though it adheres to global standards.
In Austria, finasteride prescriptions are restricted due to suicide risk concerns, with new prescriptions only for current users. Alternatives like topical finasteride, dutasteride, and online purchases face legal challenges.